Nancy Lurker insider trades: Collegium Pharmaceutical (COLL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Nancy reports to the SEC
and 2 more companies
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 13, 2026 | COLL | ↓ Sell | 4,500 | $35.97 | $162K | Direct | May 15, 2026 (2d) |
| Dec 4, 2025 | EYPT | ↓ Sell | 9,300 | $15.11 | $140K | Direct | Dec 5, 2025 (1d) |
| Nov 28, 2025 | EYPT | ↓ Sell | 700 | $14.95 | $10K | Direct | Dec 1, 2025 (3d) |
| Aug 16, 2024 | EYPT | ↑ Buy | 3,173 | $7.88 | $25K | Direct | Aug 20, 2024 (4d) |
| Jan 24, 2024 | EYPT | ↓ Sell | 35,000 | $24.98 | $874K | Direct | Jan 25, 2024 (1d) |
| Dec 4, 2023 | EYPT | ↓ Sell | 20,000 | $20.76 | $415K | Direct | Dec 6, 2023 (2d) |
| Nov 15, 2021 | EYPT | ↓ Sell | 10,000 | $20.15 | $201K | Direct | Nov 17, 2021 (2d) |
| Mar 10, 2020 | EYPT | ↑ Buy | 98,000 | $1.06 | $104K | Direct | Mar 11, 2020 (1d) |
| Mar 29, 2019 | EYPT | ↑ Buy | 28,500 | $1.76 | $50K | Direct | Apr 1, 2019 (3d) |
| Jun 14, 2017 | PSDV | ↑ Buy | 56,700 | $1.76 | $100K | Direct | Jun 14, 2017 (0d) |
| Dec 5, 2014 | AUXL | ↓ Sell | 32,430 | $34.00 | $1.1M | Direct | Dec 8, 2014 (3d) |
| Nov 10, 2014 | PDII | ↑ Buy | 49,000 | $1.75 | $86K | By Spouse | Nov 12, 2014 (2d) |
| Nov 6, 2014 | PDII | ↑ Buy | 1,000 | $1.60 | $2K | By Spouse | Nov 7, 2014 (1d) |
| Nov 5, 2014 | PDII | ↑ Buy | 55,000 | $1.74 | $96K | By IRA | Nov 7, 2014 (2d) |
| Nov 5, 2014 | PDII | ↑ Buy | 1,000 | $1.72 | $2K | By Self as Custodian for Daughter | Nov 7, 2014 (2d) |
| Aug 18, 2009 | PDII | ↑ Buy | 9,960 | $5.12 | $51K | Direct | Aug 18, 2009 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other COLL insiders
Open-market trades in the last 12 months
About Nancy Lurker's insider trades
Nancy Lurker is an insider at Collegium Pharmaceutical (COLL). Since Aug 18, 2009, Nancy has reported 9 open-market purchases worth $515K and 7 sales worth $2.9M on SEC Form 4. In the last 12 months: 3 sales ($313K).
Their filings also include grants and awards (46 filings), option exercises (28 filings), shares withheld for taxes (11 filings), gifts (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every COLL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.